NMDA receptor encephalitis with cancer of unknown primary origin

Arzu Çoban1, Gökçen Gündoğdu2, Mürüvvet Poyraz3

  • 1Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul - Turkey.

Tumori
|October 21, 2015
PubMed
Abstract

Insights

N-methyl-D-aspartate receptor (NMDAR) encephalitis, typically seen in women, can also affect men with metastatic cancer. These cases highlight a potential link between NMDAR encephalitis and slow-progressing cancers.

Area of Science:

  • Neurology
  • Oncology

Background:

  • N-methyl-D-aspartate receptor (NMDAR) encephalitis is often a paraneoplastic syndrome in young women, frequently linked to ovarian teratoma.
  • This condition involves autoimmune attacks on NMDARs, leading to severe neurological and psychiatric symptoms.

Observation:

  • Two male patients presented with NMDAR encephalitis and metastatic cancer of unknown primary origin.
  • Both patients exhibited cognitive dysfunction, neurological symptoms, EEG abnormalities, and NMDAR antibodies in serum and cerebrospinal fluid.
  • Treatment with pulse steroids and intravenous immunoglobulin was effective for their neurological symptoms.

Findings:

  • Following neurological recovery, patients developed metastatic small cell neuroendocrine carcinoma of the parotid gland and inguinal metastatic squamous cell cancer.
  • Further investigations revealed small cell lung cancer in one patient; the primary origin remained unidentified in the other.
  • These cancers demonstrated slow progression rates.

Implications:

  • NMDAR encephalitis can be associated with metastatic cancers in male patients, not exclusively young women.
  • The findings suggest that NMDAR encephalitis may precede the clinical manifestation of certain slow-progressing metastatic cancers.
  • This association warrants further investigation into the paraneoplastic potential of NMDAR encephalitis across diverse patient populations and cancer types.